Molecular Psychiatry is a high-impact journal dedicated to advancing our understanding of the molecular mechanisms underlying psychiatric disorders. It offers a multidisciplinary platform for cutting-edge research at the intersection of neuroscience, genetics, and clinical psychiatry. The journal explores the biological bases of mental illness, paving the way for innovative diagnostic and therapeutic strategies.
Key topics include genomics, proteomics, neuroimaging, and pharmacology, providing a comprehensive view of the molecular landscape of psychiatric conditions. It appeals to researchers and clinicians interested in translational research that bridges the gap between laboratory findings and clinical applications. Covered by premier indexing services, including PubMed and Web of Science, Molecular Psychiatry maintains a high standard for quality and impact.
It encourages contributions from around the globe that push the boundaries of psychiatric research. Its open access status ensures broad accessibility, enabling researchers and clinicians to stay at the forefront of the field and improve the lives of individuals affected by mental illness.